Efficacy and Safety Analysis of Carfilzomib-Containing Regimen in the Treatment of Multiple Myeloma:a Multicenter Real-World Study

被引：0
|
作者：
Liu, Na [1 ]
Wang, Luqun [2 ]
Liu, Rentong [3 ]
Zhong, Yuping [4 ]
Feng, Xianqi [5 ]
Sun, Zhongliang [6 ]
Li, Jie
Meng, Fanjun [7 ]
Ma, Junjie [8 ]
Yuan, Changyong [9 ]
Li, Hao [10 ]
Wang, Ling [11 ]
Xu, Zhilong [12 ]
Yu, Jie [13 ]
Zhang, Hao [14 ]
Chen Chunyan [15 ]
机构：
[1] Shandong Univ, Dept Hematol, Qilu Hosp, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[3] Binzhou Med Coll, Affiliated Hosp, Shandong, Peoples R China
[4] Univ Hlth & Rehabil Sci Qingdao Hosp, Qingdao Municipal Hosp, Qingdao, Peoples R China
[5] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China
[6] First Peoples Hosp Jining City, Shandong, Peoples R China
[7] Qingdao Univ, Affiliated Hosp, Qiangdao, Peoples R China
[8] Yantai Yuhuangding Hosp, Yantai, Peoples R China
[9] Shandong Univ, Dezhou Peoples Hosp, Qilu Hosp, Dezhou Hosp, Dezhou City, Peoples R China
[10] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[11] Taian Cent Hosp, Tai An, Shandong, Peoples R China
[12] Lanling Cty Peoples Hosp, Iinyi, Peoples R China
[13] Weihai Municipal Hosp, Weihai, Peoples R China
[14] Jining Med Univ, Affiliated Hosp, Jining, Peoples R China
[15] Shandong Univ, Dept Hematol, Qilu Hosp, Jinan, Shandong, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179687
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective Study
    Nasr, Fadi
    Al Ghoche, Ahmad
    Diab, Saada
    Nasr, Lewis
    Ammanouil, Emmanuel
    Riachy, Christelle
    Hallit, Souheil
    Chahine, Georges
    LEUKEMIA RESEARCH REPORTS, 2021, 15
  • [22] Efficacy and safety of carfilzomib for the treatment of multiple myeloma: An overview of systematic reviews
    Georgoulis, Vasileios
    Haidich, Anna-Bettina
    Bougioukas, Konstantinos I.
    Hatzimichael, Eleftheria
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 180
  • [23] Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients
    Raje, Noopur
    Medhekar, Rohan
    Panjabi, Sumeet
    Hines, Dionne M.
    Wang, Xin
    Iskander, Karim
    Welliver, Tim
    Wade, Rolin L.
    Ailawadhi, Sikander
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (05) : 1130 - 1139
  • [24] The efficacy and safety profiles of carfilzomib based therapy in real world practice for patients with relapsed or refractory multiple myeloma
    Jeon, Min Ji
    Yu, Eun Sang
    Kang, Ka-Won
    Lee, Byung-Hyun
    Park, Yong
    Lee, Se Ryeon
    Sung, Hwa Jung
    Choi, Chul Won
    Kim, Byung Soo
    Kim, Dae Sik
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E260 - E261
  • [25] Safety and Efficacy of Teclistamab in Patients with Relapsed/ Refractory Multiple Myeloma: A Real-World Experience
    Dima, Danai
    Davis, James A.
    Ahmed, Nausheen
    Jia, Xuefei
    Sannareddy, Aishwarya
    Shaikh, Hira
    Shune, Leyla
    Kaur, Gurbakhash
    Khouri, Jack
    Afrough, Aimaz
    Strouse, Christopher
    Lochner, Jonathan
    Mahmoudjafari, Zahra
    Raza, Shahzad
    Valent, Jason
    Anderson Jr, Larry D.
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 308.e1 - 308.e13
  • [26] A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
    Dileo, Rachel
    Mewawalla, Prerna
    Babu, Kalaivani
    Yin, Yue
    Strouse, Christopher
    Chen, Ethan
    Shaikh, Hira
    Davis, James A.
    Green, Kimberly M.
    Alkharabsheh, Omar
    Rashid, Aliya
    Pokhrel, Bidushi
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Hashmi, Hamza
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [27] Efficacy and Safety of the Topotecan-Cyclophosphamide Regimen in Adult Metastatic Ewing Sarcoma: A Large, Multicenter, Real-World Study
    Tunbekici, Salih
    Yuksel, Haydar Cagatay
    Acar, Caner
    Sahin, Gokhan
    Kinikoglu, Oguzcan
    Majidova, Nargiz
    Tunc, Mustafa Alperen
    Sali, Mursel
    Deligonul, Adem
    Karadurmus, Berkan
    Tunbekici, Ibrahim
    Gursoy, Pinar
    Sanli, Ulus Ali
    Goker, Erdem
    CANCERS, 2025, 17 (03)
  • [28] Cardiac Events in Real-World Multiple Myeloma Patients Treated with Carfilzomib: A Retrospective Claims Database Analysis
    Chari, Ajai
    Aggarwal, Sanjay K.
    Mezzi, Khalid
    Wang, Kenneth
    Kim, Christopher
    Zhu, Shao
    Braunlin, Megan
    Werther, Winifred
    Mikhael, Joseph
    BLOOD, 2016, 128 (22)
  • [29] Real-World Data in Relapsed Refractory Myeloma Patients Treated with Carfilzomib, a Multicenter Turkish Experience
    Sevindik, Omur Gokmen
    Pehlivan, Mustafa
    Tuglular, Tulin F.
    Solmaz, Serife M.
    Dogu, Mehmet Hilmi
    Yalniz, Fevzi
    Ural, Ali Ugur
    Yegen, Zafer Serenli
    Arat, Mutlu
    Ozkocaman, Vildan
    Umit, Elif G.
    Haydaroglu, Handan
    Sonmez, Sahin Mehmet
    Turgut, Mehmet
    Ozcan, Muhit
    Arslan, Onder
    Aydin, Yildiz
    Elibol, Tayfun
    Olgun, Aybuke Harmandali
    Bayar, Banu
    Tombak, Anil
    Aydogdu, Ismet
    Ozsan, Guner Hayri
    BLOOD, 2017, 130
  • [30] Efficacy and safety of tildrakizumab in elderly patients: real-world multicenter study (ESTER - study)
    Orsini, Diego
    Caldarola, Giacomo
    Dattola, Annunziata
    Campione, Elena
    Bernardini, Nicoletta
    Frascione, Pasquale
    De Simone, Clara
    Richetta, Antonio G.
    Galluzzo, Marco
    Skroza, Nevena
    Assorgi, Chiara
    Amore, Emanuele
    Falco, Gennaro M.
    Shumak, Ruslana Gaeta
    Artosi, Fabio
    Maretti, Giulia
    Potenza, Concetta
    Bianchi, Luca
    Pellacani, Giovanni
    Peris, Ketty
    Bonifati, Claudio
    Graceffa, Dario
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
12345